Examining reporting and representation of patients with cancer in COVID‐19 clinical trials

BACKGROUND: Patients with cancer are particularly vulnerable in the current COVID‐19 pandemic. Emerging evidence suggests that patients with a cancer diagnosis are three times more likely to die from COVID‐19 compared to non‐cancer patients. Due to these observed risks, it is critical that emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabow, Maya, Wang, Christine, Zhang, Sylvia, Tahir, Peggy Mary, Small, Eric J., Borno, Hala T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995191/
https://www.ncbi.nlm.nih.gov/pubmed/33621447
http://dx.doi.org/10.1002/cnr2.1355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995191/
https://www.ncbi.nlm.nih.gov/pubmed/33621447
http://dx.doi.org/10.1002/cnr2.1355

Ejemplares similares